Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

159 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A new cytokine-based dynamic stratification during induction is highly predictive of survivals in acute myeloid leukemia.
Peterlin P, Gaschet J, Guillaume T, Garnier A, Eveillard M, Le Bourgeois A, Cherel M, Debord C, Le Bris Y, Theisen O, Godon C, Mahé B, Dubruille V, Wuilleme S, Touzeau C, Gastinne T, Blin N, Lok A, Tessoulin B, Le Gouill S, Moreau P, Béné MC, Chevallier P. Peterlin P, et al. Among authors: cherel m. Cancer Med. 2021 Jan;10(2):642-648. doi: 10.1002/cam4.3648. Epub 2020 Dec 25. Cancer Med. 2021. PMID: 33369136 Free PMC article.
Syndecan-1 antigen, a promising new target for triple-negative breast cancer immuno-PET and radioimmunotherapy. A preclinical study on MDA-MB-468 xenograft tumors.
Rousseau C, Ruellan AL, Bernardeau K, Kraeber-Bodéré F, Gouard S, Loussouarn D, Saï-Maurel C, Faivre-Chauvet A, Wijdenes J, Barbet J, Gaschet J, Chérel M, Davodeau F. Rousseau C, et al. Among authors: cherel m. EJNMMI Res. 2011 Sep 1;1(1):20. doi: 10.1186/2191-219X-1-20. EJNMMI Res. 2011. PMID: 22214534 Free PMC article.
Dosimetry results suggest feasibility of radioimmunotherapy using anti-CD138 (B-B4) antibody in multiple myeloma patients.
Rousseau C, Ferrer L, Supiot S, Bardiès M, Davodeau F, Faivre-Chauvet A, Baumgartner P, Wijdenes J, Lacombe M, Barbet J, Guillaume T, Moreau P, Harousseau JL, Kraeber-Bodéré F, Cherel M. Rousseau C, et al. Among authors: cherel m. Tumour Biol. 2012 Jun;33(3):679-88. doi: 10.1007/s13277-012-0362-y. Epub 2012 Mar 3. Tumour Biol. 2012. PMID: 22389160
Antitumor immunity induced after α irradiation.
Gorin JB, Ménager J, Gouard S, Maurel C, Guilloux Y, Faivre-Chauvet A, Morgenstern A, Bruchertseifer F, Chérel M, Davodeau F, Gaschet J. Gorin JB, et al. Among authors: cherel m. Neoplasia. 2014 Apr;16(4):319-28. doi: 10.1016/j.neo.2014.04.002. Neoplasia. 2014. PMID: 24862758 Free PMC article.
Radioimmunoconjugates for the treatment of cancer.
Kraeber-Bodéré F, Bodet-Milin C, Rousseau C, Eugène T, Pallardy A, Frampas E, Carlier T, Ferrer L, Gaschet J, Davodeau F, Gestin JF, Faivre-Chauvet A, Barbet J, Chérel M. Kraeber-Bodéré F, et al. Among authors: cherel m. Semin Oncol. 2014 Oct;41(5):613-22. doi: 10.1053/j.seminoncol.2014.07.004. Epub 2014 Jul 22. Semin Oncol. 2014. PMID: 25440606 Review.
Using α radiation to boost cancer immunity?
Gorin JB, Guilloux Y, Morgenstern A, Chérel M, Davodeau F, Gaschet J. Gorin JB, et al. Among authors: cherel m. Oncoimmunology. 2014 Dec 13;3(9):e954925. doi: 10.4161/21624011.2014.954925. eCollection 2014 Oct. Oncoimmunology. 2014. PMID: 25941605 Free PMC article.
Combining α-Radioimmunotherapy and Adoptive T Cell Therapy to Potentiate Tumor Destruction.
Ménager J, Gorin JB, Maurel C, Drujont L, Gouard S, Louvet C, Chérel M, Faivre-Chauvet A, Morgenstern A, Bruchertseifer F, Davodeau F, Gaschet J, Guilloux Y. Ménager J, et al. Among authors: cherel m. PLoS One. 2015 Jun 22;10(6):e0130249. doi: 10.1371/journal.pone.0130249. eCollection 2015. PLoS One. 2015. PMID: 26098691 Free PMC article.
159 results